A Comparison of the Clinical Characteristics, Treatment Response and Survival of Patients With and Without Light Chain Glycosylation on their Monoclonal Protein in Patients Treated with Carfilzomib, Cyclophosphamide, Lenalidomide and Dexamethasone (KCRD) in the Myeloma XI Trial